KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Michael Kauffman on Q4 2020 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI) Q4 2020 Earnings Conference Call February 11, 2021 8:30 AM ET Company Participants Ian Karp - Senior Vice President, Investor and Public Relations Michael Kauffman - Chief Executive Officer Michael Mason - Chief Financial Officer John Demaree - Chief Commercial Officer Stephen Mitchener - Chief Business Officer Jatin Shah - Chief Medical Officer Conference Call Participants Maury Raycroft - Jefferies Brian Abrahams - RBC Capital Markets Peter Lawson - Barclays Jonathan Chang - SVB Leerink Michael Ulz - Baird Edward White - H.C. Wainwright Presentation Operator Good morning. My name is Vaishnavi, and I will be your conference operator for today. At this time, I would like to welcome everyone to Karyopharm Therapeutics' Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions] Please be advice that this call is being recorded at the company's request. I would now like to turn the call
For further details see:
Karyopharm Therapeutics Inc. (KPTI) CEO Michael Kauffman on Q4 2020 Results - Earnings Call Transcript